Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS

Table 4

Adverse outcomes [6].

	Odds ratio (95% CI)	value
Myocardial infarction; (combined comparator drugs)	1.43 (1.03–1.98)	0.03
Death from CV causes; (combined comparator drugs)	1.64 (0.98–2.74)	0.06